Showing results (1031-1040 of 3,360) with videos related to
Sort By:
Pageof 336
Annals of Nuclear Medicine|October 30, 2009
FDG PET findings in a case with acute pulmonary silicosisMetin Ozkan, Asli Ayan, Deniz Arik, et al.Annals of Nuclear Medicine|October 31, 2009
Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography of breast cancer in detecting axillary lymph node metastasis: comparison with ultrasonography and contrast-enhanced CTShuichi Monzawa, Shuji Adachi, Kayo Suzuki, et al.Annals of Nuclear Medicine|December 10, 2009
Study on biodistribution and imaging of radioiodinated arginine-arginine-leucine peptide in nude mice bearing human prostate carcinomaMingming Yu, Haizhong Zhou, Xiaoqiang Liu, et al.Annals of Nuclear Medicine|December 4, 2009
Incidental detection of Sertoli-Leydig cell tumor by FDG PET/CT imaging in a patient with androgen insensitivity syndromeTamer Ozülker, Tevfik Ozpaçaci, Filiz Ozülker, et al.Annals of Nuclear Medicine|May 1, 1992
SPECT demonstration of splenosisS Yoshida, T Suematsu, T Motohara, et al.Annals of Nuclear Medicine|October 27, 2005
Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancerYoshihiro Nishiyama, Yuka Yamamoto, Koiku Yokoe, et al.Annals of Nuclear Medicine|October 27, 2005
Unilateral temporary functional stasis in the upper urinary tract caused by "a filled bladder" on Tc-99m DTPA diuresis renography: a teaching caseOzgur Karacalioglu, Seyfettin Ilgan, Nuri Arslan, et al.Annals of Nuclear Medicine|January 9, 2010
Design and performance from an integrated PET/MRI system for small animalsSeiichi Yamamoto, Masao Imaizumi, Yasukazu Kanai, et al.Annals of Nuclear Medicine|January 9, 2010
The effect of giving detailed information about intravenous radiopharmaceutical administration on the anxiety level of patients who request more informationEser Kaya, Ismail Ciftci, Reha Demirel, et al.Annals of Nuclear Medicine|November 19, 2009
Preparation and evaluation of 186/188Re-labeled antibody (A7) for radioimmunotherapy with rhenium(I) tricarbonyl core as a chelate siteKazuma Ogawa, Hidekazu Kawashima, Seigo Kinuya, et al.Pageof 336